355 related articles for article (PubMed ID: 11199370)
1. In situ expression of transforming growth factor-beta1-3, latent transforming growth factor-beta binding protein and tumor necrosis factor-alpha in liver tissue from patients with chronic hepatitis C.
Kinnman N; Andersson U; Hultcrantz R
Scand J Gastroenterol; 2000 Dec; 35(12):1294-300. PubMed ID: 11199370
[TBL] [Abstract][Full Text] [Related]
2. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.
Marek B; Kajdaniuk D; Mazurek U; Janczewska-Kazek E; Kos-Kudla B; Strzalka B; Fila A; Niedziolka D; Beniowski M; Ostrowska Z; Borgiel-Marek H; Kajdaniuk J; Sieminska L; Nowak M; Wilczok T; Pakula D; Filipczyk P
J Clin Pharm Ther; 2005 Jun; 30(3):271-7. PubMed ID: 15896245
[TBL] [Abstract][Full Text] [Related]
4. TGF-β isoforms inhibit hepatitis C virus propagation in transforming growth factor beta/SMAD protein signalling pathway dependent and independent manners.
Zou LL; Li JR; Li H; Tan JL; Wang MX; Liu NN; Gao RM; Yan HY; Wang XK; Dong B; Li YH; Peng ZG
J Cell Mol Med; 2021 Apr; 25(7):3498-3510. PubMed ID: 33682288
[TBL] [Abstract][Full Text] [Related]
5. Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.
Guido M; De Franceschi L; Olivari N; Leandro G; Felder M; Corrocher R; Rugge M; Pasino M; Lanza C; Capelli P; Fattovich G
Mod Pathol; 2006 Aug; 19(8):1047-54. PubMed ID: 16699498
[TBL] [Abstract][Full Text] [Related]
6. Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
Shirasaki T; Honda M; Shimakami T; Murai K; Shiomoto T; Okada H; Takabatake R; Tokumaru A; Sakai Y; Yamashita T; Lemon SM; Murakami S; Kaneko S
Hepatology; 2014 Nov; 60(5):1519-30. PubMed ID: 24962339
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
[TBL] [Abstract][Full Text] [Related]
8. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Janczewska-Kazek E; Marek B; Kajdaniuk D; Borgiel-Marek H
World J Gastroenterol; 2006 Feb; 12(6):961-5. PubMed ID: 16521228
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of cyclooxygenase-2 and transforming growth factor-beta 1 is an independent predictor of poor virological response to interferon therapy in chronic HCV genotype 4 patients.
Gomaa WM; Ibrahim MA; Shatat ME
Saudi J Gastroenterol; 2014; 20(1):59-65. PubMed ID: 24496160
[TBL] [Abstract][Full Text] [Related]
10. Liver portal fibrosis in dioxin receptor-null mice that overexpress the latent transforming growth factor-beta-binding protein-1.
Corchero J; Martín-Partido G; Dallas SL; Fernández-Salguero PM
Int J Exp Pathol; 2004 Oct; 85(5):295-302. PubMed ID: 15379962
[TBL] [Abstract][Full Text] [Related]
11. Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Neuman MG; Benhamou JP; Bourliere M; Ibrahim A; Malkiewicz I; Asselah T; Martinot-Peignoux M; Shear NH; Katz GG; Akremi R; Benali S; Boyer N; Lecomte L; Le Breton V; Le Guludec G; Marcellin P
Cytokine; 2002 Jan; 17(2):108-17. PubMed ID: 11886178
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
[TBL] [Abstract][Full Text] [Related]
13. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
[TBL] [Abstract][Full Text] [Related]
15. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
Roth-Eichhorn S; Kühl K; Gressner AM
Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
[TBL] [Abstract][Full Text] [Related]
16. Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
Flisiak R; Jaroszewicz J; Lapinski TW; Flisiak I; Prokopowiczi D
World J Gastroenterol; 2005 Nov; 11(43):6833-8. PubMed ID: 16425392
[TBL] [Abstract][Full Text] [Related]
17. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
Roth S; Schurek J; Gressner AM
Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
[TBL] [Abstract][Full Text] [Related]
18. [Serum aminoterminal peptide of type III procollagen (PIIINP) and transforming growth factor-beta1 (TGF-beta1) levels in patients with chronic hepatitis B and C].
Marek B; Kajdaniuk D; Janczewska-Kazek E; Beniowski M; Swietochowska E; Kos-Kudła B; Ostrowska Z; Mazurek U; Wilczok T; Nowak M; Siemińska L; Borgiel-Marek H; Strzyzewski A; Januła A; Sierek K; Niedzielski Z
Pol Arch Med Wewn; 2003 Jun; 109(6):603-8. PubMed ID: 14567092
[TBL] [Abstract][Full Text] [Related]
19. Expression of isoforms and splice variants of the latent transforming growth factor beta binding protein (LTBP) in cultured human liver myofibroblasts.
Mangasser-Stephan K; Gartung C; Lahme B; Gressner AM
Liver; 2001 Apr; 21(2):105-13. PubMed ID: 11318979
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas.
Stracke S; Konner K; Köstlin I; Friedl R; Jehle PM; Hombach V; Keller F; Waltenberger J
Kidney Int; 2002 Mar; 61(3):1011-9. PubMed ID: 11849456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
